Ecological Impact And Sustainable Development Implications Of Ayush Industry Exemption On Biodiversity Act And Benefit Sharing: A Theoretical Analysis.

Abstract

Changes to India's biodiversity management framework brought about by the Biological Diversity (Amendment) Act (BDAA), 2023 will influence the AYUSH sector. In this study, we look at what happens if the Biological Diversity Act (BDA) of 2002 doesn't apply to AYUSH practitioners and people who employ codified conventional wisdom. The modifications aim to promote growth and innovation in conventional medicine by simplifying rules, encouraging the cultivation of medicinal plants, and streamlining methods for obtaining biological resources. One fundamental premise of the Act is fair along with equitable benefit-sharing, however the act has been the subject of controversy due to its exemptions. Some people are worried that the changes could damage local and indigenous communities’ rights and lead to the exploitation of their ecological resources. The study delves into the delicate balancing act of safeguarding conventional understanding and community rights while simultaneously fostering economic development in the AYUSH sector. To advance the conventional medicine industry while protecting biodiversity, the results stress the need of better definitions and procedures.